Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

A hair test shows promise for early mood disorder diagnosis.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Phenylalanine may help with depression but can cause issues if not properly processed.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Early diagnosis of colorectal cancer in young patients with certain symptoms is crucial for better outcomes.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Children with autism have lower levels of essential and toxic trace elements in their hair.

Gene expression in hair follicles can help diagnose methamphetamine use disorder.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Cactus-enriched hair oil effectively reduces hair fall and promotes hair growth with no major side effects.

Finasteride may cause depression and suicidal thoughts, especially in young men.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

Eating disorders often cause skin issues, which can help in early diagnosis and treatment.

Many women with PCOS in Saudi Arabia suffer from depression and anxiety.

Treating scalp issues in hair-pulling disorder helps hair regrow and reduces itch.